ALXO

Alx Oncology Holdings Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth↑ 7/10
  • Value↓ 4/10
Alx Oncology Holdings sales and earnings growth
ALXO Growth
Good
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 39.18%
  • FCF Y/Y↑ 28.15%
Alx Oncology Holdings gross and profit margin trends
ALXO Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -100.80%
Alx Oncology Holdings net debt vs free cash flow
ALXO Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -57.2

Alx Oncology Holdings stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks